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Objective: To identify proximate causes (‘triggers’) of flares in adults with, or at risk of, knee 
osteoarthritis (OA), estimate their course and consequences, and determine higher risk 
individuals. 
Methods: In this 13-week web-based case-crossover study adults aged ≥40 years, with or 
without a recorded diagnosis of knee OA, and no inflammatory arthropathy who self-reported a 
knee flare completed a questionnaire capturing information on exposure to 21 putative activity-
related, psychosocial and environmental triggers (hazard period, ≤72 hours prior). Comparisons 
were made with identical exposure measurements at four 4-weekly scheduled time points (non-
flare control period) using conditional logistic regression. Flare was defined as a sudden onset of 
worsening signs and symptoms, sustained for ≥24 hours. Flare characteristics, course and 
consequence were analysed descriptively. Associations between flare frequency and baseline 
characteristics were estimated using Poisson regression. 
Results: Of 744 recruited participants (mean age (SD) 62.1 (10.2) years; 61% female), 376 
reported 568 flares (hazards) and provided 867 valid control period measurements. Thirteen 
exposures (8 activity-related, 5 psychosocial/environmental) were positively associated with flare 
onset within 24 hours (strongest odds ratio estimate, knee buckling: 9.06: 95% confidence 
interval [CI] 5.86, 13.99; weakest, cold/damp weather: 1.45: 95%CI 1.12, 1.87). Median flare 
duration was 5 days (IQR 3, 8), less common if older (incident rate ratio [IRR] 0.98: 95%CI 0.97, 
0.99), more common if female (IRR 1.85: 95%CI 1.43, 2.39). 
Conclusions: Multiple activity-related, psychosocial and environmental exposures are implicated 
in triggering flares. This evidence can help inform prevention and acute symptom management 



















Osteoarthritis (OA) is a multifactorial syndrome, with heterogeneous long-term trajectories 3 
(e.g.1) punctuated by variable episodes of increased pain2. Inflammation is common in OA3 and 4 
although the lived experience involves complex biopsychosocial interactions, pain is a cardinal 5 
feature4 and the main reason patients seek healthcare.5 6 
 7 
Unpredictable pain, or episodic flare, can be distressing and disabling for patients2, disruptive to 8 
active lifestyle behaviours and chronic disease management6; often leading to work loss and 9 
increased healthcare use. Understanding proximate causes of flares is methodologically 10 
challenging but important for patients and clinicians to be able to prevent or minimise their 11 
impact. 12 
  13 
Building on successful applications in acute-onset disease (e.g. myocardial infarction7 and ‘acute-14 
on-chronic’ conditions (e.g. gout8)), self-controlled and case-crossover study designs are 15 
emerging within the musculoskeletal pain/OA literature (e.g.9-13). These designs are efficient for 16 
identifying ‘acute-on-chronic’ events and recurrent exposures within patients. In OA, modifiable 17 
excessive or aberrant load exposures to weight-bearing joints are important drivers of 18 
aetiopathogenesis14. In this study, we postulate that intermittent or transient activity-related 19 
exposures, including high joint loading activities, are causes of recurrent flares with important 20 
implications for acute symptom management and long-term self-management15. 21 
 22 
In the ACT-FLARE study (ACuTe FLAREs in knee OA), our primary objective was to identify 23 
common, consistent proximate causes (‘triggers’) of flares in adults with, or at risk of, knee OA. 24 
Secondary objectives were to, i) estimate flare time course and consequences, and ii) determine 25 















Study design and sample 30 
Adults aged ≥40 years who were resident in England with knee pain, with or without a recorded 31 
knee OA diagnosis, with daily access to the internet, and ability to complete questionnaires in 32 
English were invited to take part in a 13-week web-based case-crossover study15,16. Exclusions 33 
included inflammatory arthropathies (including gout), fibromyalgia, joint replacement in the 34 
flaring knee or knee surgery in the last three months. Participants were identified via three 35 
methods: (1) Fifteen general practice (GP) registers (ten, West Midlands; five, South East). 36 
Patients with a relevant Read-coded consultation for knee OA or knee OA-related joint 37 
symptoms in the last two years were identified and invited via mailed invitation and one 38 
reminder. (2) Offline community advertisement. Study posters, flyers and business cards were 39 
displayed in general practices, pharmacies, hospitals and public libraries across England, where 40 
permission was granted. (3) Online social media advertisement. Using Facebook, adverts were 41 
targeted at adults ≥40 years. For methods 2 and 3, advertisements directed people to the study 42 
registration page where eligibility against the criteria detailed above was self-declared. Ethical 43 
approval was obtained from Yorkshire & The Humber-Leeds East Research Ethics Committee 44 
(REC reference number: 18/YH/0075). All participants provided informed electronic-consent. 45 
 46 
Data collection 47 
Consenting participants who registered an account for login access to the ACT-FLARE study 48 
website were invited to complete a Baseline questionnaire, four Scheduled questionnaires 49 
(measurement/ascertainment of exposures during control period) and an Event-Driven 50 
questionnaire (hazard period) each time they experienced a flare of their knee pain (Fig. 1).  51 
 52 













The Baseline questionnaire gathered information on aspects of knee pain17-26, healthcare use for 55 
knee pain26, general health/physical activity27-29, and demographic characteristics.  56 
 57 
The Scheduled questionnaires, sent at weeks 1, 5, 9 and 13 after Baseline questionnaire 58 
completion, featured a matrix reporting exposure to 21 putative activity-related, psychosocial and 59 
environmental triggers29-33 (see Supplementary Data Q1). Questions were answered for day of 60 
completion and the 3 days before this. The response options for nine potential trigger questions 61 
relating to physical activities were ‘not at all’, ‘a little’ or ‘a lot’. For the remaining 12 questions 62 
responses options were ‘no/yes’.  63 
 64 
Participants who experienced a flare were invited to complete an Event-Driven questionnaire, 65 
designed to capture information about the flare and the same potential trigger exposures as in 66 
the Scheduled questionnaires, during the day of the flare and the 3 days prior15. The Event-67 
Driven questionnaire also invited participants to answer yes/no to a question asking if the flare 68 
was unexpected. They were then invited to complete a Daily questionnaire on pain intensity30, 69 
bothersomeness24, medication use and participant judgement of flare resolution each day until 70 
their flare ended. Resolution was defined a priori as return to pre-flare ‘normal’ state for two 71 
consecutive days15, however this was relaxed to one confirmation due to the lower than expected 72 
proportion (36%) meeting the initial definition. 73 
 74 
Patient involvement 75 
A Patient Advisory Group confirmed OA flares to be a research priority, provided advice and 76 
suggestion across all aspects of preliminary feasibility and pilot work, and inputted to procedures 77 
and processes for this full-scale study from inception to dissemination15,16. Engagement was via 78 












applicant on the initial research proposal and participated in regular Project Management team 80 
meetings across the project lifecycle.  81 
 82 
Outcome definition 83 
Self-reported flare of symptomatic knee OA was defined as “an event in the natural course of 84 
the condition characterized by a change in the participant’s baseline pain that is beyond normal 85 
day-to-day variation, sustained for at least 24 hours, and is sudden or quick in onset. It may 86 
impact on the ability to perform everyday activities and result in an increase in analgesic 87 
intake”15,p9. This self-determined definition was derived from our pilot study16, previous literature 88 
review34, discussions with patients and members of the public, and findings from previous survey 89 
and daily diary studies35. Written explanation and short videos about flares, developed with 90 
patients and presented by our patient co-investigator (CP) and clinician-researcher (MJT), were 91 
available to view on the ACT-FLARE website for all enrolled and prospective participants for 92 
the study duration.  93 
 94 
Questionnaire validity 95 
To ensure exposure information was not influenced by a previous flare, questionnaires were only 96 
valid for analysis if there was ≥4 days between completion of all hazard and control period 97 
questionnaires, and between each flare ending and completion of control period questionnaires. 98 
 99 
Statistical analysis 100 
Describing the sample 101 
Our sample size calculation ensured adequate numbers of self-reported flares to sufficiently 102 
power the primary analysis identifying potential triggers of knee OA flare15. The target sample 103 
was 434 participants experiencing a flare. Where available, we compared sociodemographic 104 












recruitment method. Summary descriptive statistics were derived for participant demographics 106 
and self-reported knee characteristics, as well as features of flares, symptoms, and consequences 107 
during flares. Baseline data were collected for left and right knee. For descriptive knee 108 
characteristics, the worst knee was selected and reported based on highest ‘average pain’ score on 109 
a 0-10 numerical rating scale (NRS).  If scores were equal, the knee with the highest ‘worst pain 110 
in the last week’ followed by the highest ‘current pain’, followed by random selection were 111 
selected. If left, or right knee score was missing, the available knee score was included. 112 
 113 
Primary analysis: proximate trigger exposure measurement 114 
With each participant acting as their own control in the analysis, reported trigger exposures in 115 
the hazard periods were compared to those reported in the control periods, using conditional 116 
logistic regression with m:n matching, so each participant could potentially contribute multiple 117 
hazard and control periods36. All available controls were utilised and may have occurred before 118 
and/or after the hazard period. Odds ratios (OR) with 95% confidence intervals (CI) were 119 
derived. Time trends in exposure were examined by comparing exposure frequency across the 120 
Scheduled questionnaires at weeks 1, 5, 9 and 13, and before and after the flare. A sensitivity 121 
analysis of the primary analysis was restricted to flares that had control periods occurring before 122 
and after the hazard period. To explore the exposure induction period, trigger exposure status 123 
was compared for day of completion/ flare and the 3 days earlier. The proportion of flares 124 
deemed unexpected was reported. Sensitivity analyses were conducted by restricting analysis to 125 
first flare per participant (to examine carryover effects for multiple flares), flares reported within 126 
3 days of flare onset (to reduce the potential impact of delayed recall), flares reported after 127 
baseline (i.e., excluding people who reported to be experiencing a flare at study entry, which 128 
could influence how initial questions were answered), spontaneous self-directed flares reported 129 
without prompt (i.e., not at Scheduled questionnaire time points15), and participants recruited 130 













Secondary analysis 1: estimating time course and consequences 133 
Analysis was restricted to participants who reported Event-Driven flare questionnaires and 134 
indicated via Daily questionnaires their flare had ended. Unresolved flares were excluded from 135 
the analysis as the distribution of flare duration was more skewed (median 19 (5, 87) days) than 136 
resolved flares 6 days (3, 11). Flare characteristics, and daily course and consequences (pain, 137 
bothersomeness, medication use in last 24 hours) were analysed descriptively. The Kaplan-Meier 138 
curve for time to flare resolution was derived. Effects of covariates on time to flare resolution 139 
were assessed using accelerated failure-time model, with generalised gamma survival distribution 140 
yielding unadjusted time ratios and 95%CI.  141 
 142 
Secondary analysis 2: frequency of acute flares 143 
Analysis was restricted to participants who completed at least two Scheduled questionnaires: the 144 
prespecified minimum amount of engagement with study follow-up required for inclusion. 145 
Poisson regression with robust standard errors examined the effect of selected baseline 146 
participant or knee symptom characteristics on the number of reported flares over the 13-week 147 
follow-up period. Unadjusted incidence rate ratios (IRR) and 95%CI were calculated.  148 
 149 
All analyses were conducted using STATA V.15.0 (Stata Corporation, Texas, USA).  150 
 151 
RESULTS 152 
Study population 153 
Between July 2018 and February 2019, emails were sent to 1454 potentially eligible participants, 154 
of whom 744 responded, were eligible and consented to participate (recruitment source: GP 155 
registers (515), online advertisement (129), offline advertisement (57), unknown (43)). 156 












S1-5). The key descriptive characteristics of the 744 respondents are provided in Table II 158 
(Supplementary Tables S6-8). 159 
[Table I] 160 
[Table II] 161 
        162 
Proximate triggers of acute flares 163 
During the study period, 714 flares were reported by 493 participants. For the primary analysis, 164 
376 participants provided ≥1 control period and ≥1 hazard period (mean age, SD 61.8 (10.1) 165 
years; 68% female and mean body mass index (SD) 29.5 (5.9) kg/m2), resulting in 568 flares 166 
(hazards) and 867 controls for analysis (Table III). The distribution of baseline characteristics 167 
was generally similar between the 376 eligible and 368 ineligible participants in this analysis, 168 
although eligible participants had a higher prevalence of females. Target sample size was 169 
exceeded. Thirteen exposures (six physical activities) were positively associated with flare onset 170 
within 24 hours. The overall strongest positive association was with knee buckling (OR 9.06: 171 
95%CI 5.86, 13.99). The strongest positive physical activity association was with squatting or 172 
kneeling (OR (‘a lot’ vs ‘not at all’), 3.30: 95%CI 1.95, 5.59). Three exposures were inversely 173 
associated with flares: sitting for long periods without a break (OR 0.67: 95%CI 0.46, 0.98), 174 
reducing or missing planned medication (OR 0.34: 95%CI 0.18, 0.63) and cough, cold or minor 175 
infection (OR 0.72: 95%CI 0.52, 0.99). The frequency of most physical activity exposures 176 
suggested a graded relationship with risk of flare (a lot > a little > not at all). Going up/down 177 
stairs, driving, stressful events at work, home, and friend/family related stress were not 178 
statistically significantly associated with flares. Flares were reported as unexpected by 70% of 179 
participants. Exposure-outcome associations were strongest for exposures occurring within 24 180 
hours; exposures up to 3 days prior had lower, if any, significant associations with risk of flare 181 













[Table III] 184 
 185 
There was little evidence of time trends in exposure during the 13-week study period. The trigger 186 
exposure prevalence remained constant across the four Scheduled questionnaires, and before 187 
and after a flare was reported. Furthermore, restricting the analysis to flares with control periods 188 
on either side of the flare had little impact on the odds ratio estimates (data not shown).  189 
 190 
Sensitivity analyses restricted to first flare per participant, flares notified within 3 days of onset, 191 
flares reported after baseline, without prompt and general practice recruited participants only, did 192 
not change the overall interpretation (data not shown). Rates of missing data for triggers were 193 
low, with ≥95% of hazard and control periods utilised in modelling.  194 
 195 
Time course and consequences of acute flares 196 
Based on 314 participants providing 459 flares with known resolution date, the median 197 
(interquartile range) flare duration was 5 (3, 8) days (Supplementary Table S10; Fig. 2). The first 198 
recorded NRS pain score was ≥2 compared to average pain at baseline in 44% of participants 199 
reporting flares on day of onset. Knee changes noticed since flare onset included stiffness (64%), 200 
limping (58%), increased difficulty with everyday activities (57%), sleep disturbance (48%) and 201 
swelling (33%). (Supplementary Table S11). Levels of pain, bothersomeness and medication 202 
usage reduced over flare episodes (Supplementary Fig. S3; Table S12). No associations were 203 
found between age, gender or symptom duration and time to flare resolution, however those 204 
with longer symptom duration appeared to have slightly slower resolution (Supplementary Table 205 
S13). 206 
  207 













Frequency of acute flares 210 
Among 476 participants who engaged throughout study follow-up, 242 (51%) reported ≥1 flare. 211 
Flares were less common in older ages (IRR 0.98: 95%CI 0.97, 0.99), and more common in 212 
females (IRR 1.85: 95%CI 1.43, 2.39), and those with severe frequent knee pain at baseline (IRR 213 
2.06: 95%CI 1.17, 3.63). Associations with prior knee injury/surgery and deprivation were weak 214 
or absent (Supplementary Table S14). These 476 participants had better knee pain, physical 215 
function and quality of life than the 268 participants who did not engage in the study 216 
(Supplementary Table S15 compares baseline characteristics across ineligible and eligible 217 
participants for each primary and secondary objective analysis). 218 
 219 
DISCUSSION 220 
Our study provides a comprehensive examination of flare triggers, episode duration and 221 
characterisation of higher risk individuals within a large community-based sample of people with, 222 
or at risk of, knee OA. We found that a wide range of activity-related, psychosocial and 223 
environmental factors transiently increase the risk of an acute flare that typically goes on to last 224 
3-8 days, with two-thirds of sufferers experiencing increased stiffness alongside pain. Flares were 225 
most likely to manifest within 24 hours of exposure and the strongest positive associations were 226 
with physical activity-based exposures. Although flares were slightly more common amongst 227 
younger participants of working age, females and those with severe frequent knee pain at 228 
baseline, the self-selecting nature of the sample and the possibility that females were more likely 229 
to engage with the flare notification system should be recognised. 230 
 231 
The direction of our observed associations with exposure to one or more physical activities is 232 
consistent with previous study35, as is our positive association with knee buckling.37 More 233 
broadly, our observed associations with a range of physical and psychosocial exposures are 234 












Contrasting observations on psychological associations with hip OA39, may be explained by 236 
different exposure measurements. Although our positive association with cold/damp weather 237 
contrasts previous study40, our brief self-report exposure measurement is crude by comparison to 238 
the objective weather analysis by Ferreira et al40.      239 
 240 
Collectively, our observations provide support for our hypothesis that intermittent activity-241 
related exposures are risk factors for flares. Mechanical exposures, including occupational 242 
physical loading41,42, often associated with incidence and progression, may also contribute to 243 
‘acute-on-chronic’ flares. These exposures have been proposed to have an aetiological role, and 244 
also represent potentially modifiable risk factors for the aetiopathogenesis14. In the absence of 245 
traumatic events (injury), the periodic sudden onset of increased pain (acute flare) may represent 246 
short-lived consequences of transient mechanical exposures. Whilst the low-level cumulative and 247 
repetitive nature of these exposures may be important for the OA aetiopathogenesis, they are 248 
likely to be frequent day-to-day encounters, often experienced as innocuous events for many 249 
people and not always causal antecedents to a flare43. Interestingly, 70% of flares reported during 250 
the study were reported as unexpected, but the majority (two-thirds) hold the belief that 251 
physical/mechanical factors are their most likely triggers. Further research is needed to confirm 252 
whether the cumulative frequency of flare episodes drives OA aetiopathogenesis43. Our observed 253 
median five-day flare duration, is broadly consistent with previous estimates35,44. The nature of 254 
trigger exposures and the duration of flare episodes are important insights for patient-healthcare 255 
professional consultations, particularly as our data suggest flares appear more common among 256 
working age adults. 257 
 258 
Collaboratively with patients we defined a self-reported flare lasting ≥24 hours to represent a 259 
sudden change in perceived pain state, irrespective of pain score. Whilst previous studies have 260 












group preferred a more patient-centred approach. Previous work by Marty et al.46 showed clearly 262 
that patient-identified flares agreed well with clinician-defined flares. The similarity of findings 263 
with others11,13,35,37 also provide some valuable replication and suggest that these associations may 264 
not be too highly sensitive to this choice of flare definition.  Other signs and symptoms, for 265 
example, stiffness, swelling and functional impact may be earlier or more important initial 266 
symptoms associated with flare onset. Defining flares and their mechanism of action are 267 
important research priorities. Knee changes noticed since flare onset by participants in our study 268 
are consistent with important patient-centred flare domains previously identified by international 269 
consensus47. In our sample, the proportion of participants, willing in principle, to provide a 270 
magnetic resonance imaging scan or knee joint aspiration during a future flare was 92% and 271 
77%, respectively in 376 responders. 272 
 273 
Strengths of this self-controlled observational study are that all fixed or slow-varying person-274 
level confounding is eliminated by design and the web-based data collection facilitates real-time 275 
data capture. Our findings should be interpreted in the context of several methodological 276 
limitations. First, for participants recruited via community-advertising (31%), eligibility criteria 277 
were defined by participant self-report. However, by restricting the primary analysis to those 278 
recruited via GP registers with objective support for their knee OA status, the overall 279 
interpretation remained the same. Second, although many of the selected potential triggers were 280 
based on previous literature, our brief items for categorising exposure levels have not been 281 
validated against longer-form self-report or objective measurements (where these are available). 282 
However, our approach was intended to enable direct comparison across related exposures and 283 
facilitate the examination of induction time, by reducing participant burden when invited to 284 
recall responses to repeated questions over 3-day periods. In keeping with the focus on within-285 
person change in case-crossover studies, our underlying assumption was that change in exposure 286 












exposure’) was likely to be most important. Future studies using more detailed self-report or 288 
objective measurement would be able to test this assumption although due to respondent burden 289 
they would most likely be restricted to a single or smaller set of exposures than the current study. 290 
Third, while confounding between exposures is still possible, correlations between exposures 291 
was low (≤0.4), therefore independence was assumed and the potential to combine related 292 
exposures (e.g. Rasch analysis) was not supported. Fourth, the study design remains vulnerable 293 
to differential recall bias between retrospective data ascertainment at Scheduled and Event-294 
Driven (flare) questionnaires. If flares were reported more than 1 day after onset, recall time 295 
between hazard periods and control periods may be different. Direct matching of exposure recall 296 
time between hazard and control periods illustrated variations in direction and magnitude of 297 
some estimates, suggesting there may be some random differential misclassification, although the 298 
sample was smaller (data not shown). Fifth, our flare resolution definition was relaxed from 299 
confirmation on two consecutive days, to one confirmation, as only 36% fulfilled the a priori 300 
definition. Also 128 participants did not complete daily questionnaires and the majority had at 301 
least one missing day. Flares for which we did not receive confirmation of their resolution were 302 
excluded from our analysis estimating the duration of flares. Excluded flares include those that 303 
had not resolved by the end of the study period (censored) and those that had resolved but 304 
where participants had not provided confirmation of this (unobserved resolution). We cannot 305 
know the exact effect of this on biasing our estimate of flare duration, but censoring would tend 306 
to result in systematic under-estimation of flare duration. Our estimate of median flare duration 307 
should therefore be treated as conservative. If some flares ended before they were reported the 308 
flare duration may be overestimated. Finally, participant ethnicity was not captured. 309 
 310 
In summary, this study provides evidence for multiple activity-related, psychosocial and 311 
environmental proximate exposures that can trigger acute flares in adults with, or at risk of, knee 312 












and females more frequently. These findings support the view that exposures associated with 314 
incidence and progression are also potential risk factors for acute flares. This evidence can help 315 
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Figure Legends 537 
Fig 1. Schematic representation of the 13-week ACT-FLARE case-crossover study design. 538 












Table I. Age, gender and deprivation scores between responders at each data collection point. 












 (N=744) (N=591) (N=493) 
Female 451 (61) 361 (61) 323 (66) 
Age (years) (Mean (SD)) 62.1 (10.2) 62.4 (10.1) 61.8 (10.3) 
<55 185 (25) 141 (24) 129 (26) 
55-64 247 (34) 195 (34) 168 (35) 
65+ 299 (41) 247 (42) 190 (39) 
Males age (Mean (SD)) 63.7 (10.4) 64.5 (10.1) 63.7 (10.7) 
<55 59 (20) 41 (18) 36 (21) 
55-64 90 (31) 70 (31) 49 (29) 
65+ 140 (48) 116 (51) 83 (49) 
Females age (Mean (SD)) 61.0 (10.0) 61.1 (9.9) 60.8 (10.0) 
<55 126 (29) 100 (28) 93 (29) 
55-64 157 (36) 125 (35) 119 (37) 
65+ 159 (36) 131 (37) 107 (34) 
IMD    
Most deprived 99 (13) 74 (13) 73 (15) 
2nd most deprived 137 (18) 103 (17) 94 (19) 
Mid-deprived 174 (23) 141 (24) 113 (23) 
2nd least deprived 191 (26) 149 (25) 123 (25) 












          Table II. Participant and knee characteristics of sample. 
Characteristic Baseline responders 
(N=744) 
Participant characteristic  
Age (years); mean (SD) 62.1 (10.2) 
Female 451 (61) 
Current employment 
      Employed/Self-employed 
      Retired 
      Looking after home and/or family 
      Unable to work (sick/disabled) 
      Unemployed/Voluntary work 
      Full, part-time student 







 2 (<1) 
 6 (1) 
BMI (kg/m2); mean (SD) 29.2 (5.7) 
Family history of total/partial knee replacement 112 (15) 
Knee characteristic*  
Time since onset of pain 
     < 1 year ago 
      1 to 4 years ago 
      5 to 9 years ago 






Knee pain pattern in the last year 
      Single episode 
      Few episodes 
      Few episodes and some pain 
      Severe episodes and up and down pain 







Pain experience over last 6 months 
      No knee pain 
      Pain is predictable 
      Predictable, becoming more unpredictable 






Pain, aching, stiffness last month 
      None 
      Few days, 
      Some days 
      Most days 







Worse pain last week (0-10 NRS); mean (SD) 5.5 (2.7) 
Least pain last week (0-10 NRS); mean (SD) 3.4 (2.9) 
Average pain (0-10 NRS); mean (SD) 4.8 (2.4) 
Pain right now (0-10 NRS); mean (SD) 
Bothersomeness of knee pain in the last 24 hours 
      Not at all 
      Slightly,  
      Moderately 
      Very much 
      Extremely 
KOOS Physical Function (0-100); mean (SD)† 





















             Table II. Continued… 
 
Characteristic Baseline responders 
(N=744) 
Flare at present 
Varus-valgus malalignment 
      Very bow legged 
      Bow legged 
      Normal 
      Knock-knee 








      Very turned out feet 
      Turned out feet 
      Straight 
      Turned in feet 







Previous knee injury 399 (54) 
            Figures are numbers (%) unless otherwise stated. 
*The index knee was selected based on the knee with highest ‘average pain’ score on a 0-10 numerical 
rating scale. If scores were equal, then the knee with the highest ‘worst pain in the last week’ followed by 
the highest ‘current pain’, followed by random selection were selected. If left, or right knee score was 
missing, the available knee score was included. 
†Higher scores indicate worse physical function. 
‡Lower scores indicate worse quality of life. 
SD, Standard Deviation; BMI, Body Mass Index; NRS, Numerical Rating Scale; KOOS, knee injury and 













Table III. Associations between potential trigger exposures and knee OA flare onset 
within 24 hours (n=376 participants). 








OR (95% CI) 
Physical activities    
Walking outside without a rest    
          Not at all 213 (25) 113 (20) 1 
          A little 476 (55) 292 (52) 1.34 (0.97, 1.86) 
          A lot 172 (20) 154 (28) 2.41 (1.63, 3.57) 
Standing for long periods without a rest    
          Not at all 362 (42) 201 (36) 1 
          A little 408 (47) 237 (43) 1.14 (0.86, 1.52) 
          A lot 91 (11) 119 (21) 3.29 (2.22, 4.87) 
Sitting for long periods without a break    
          Not at all 199 (23) 158 (28) 1 
          A little 451 (52) 259 (46) 0.65 (0.48, 0.89) 
          A lot 213 (25) 141 (25) 0.67 (0.46, 0.98) 
Moderate-to-vigorous physical activity    
          Not at all 414 (48) 272 (49) 1 
          A little 336 (39) 187 (33) 0.90 (0.67, 1.20) 
          A lot 108 (13) 100 (18) 1.64 (1.12, 2.39) 
Going up and down stairs    
          Not at all 133 (16) 85 (15) 1 
          A little 521 (61) 337 (61) 1.14 (0.73, 1.79) 
          A lot 206 (24) 134 (24) 1.35 (0.82, 2.23) 
Driving    
          Not at all 365 (43) 238 (43) 1 
          A little 404 (48) 257 (47) 0.96 (0.71, 1.30) 
          A lot 80 (9) 58 (10) 1.03 (0.63, 1.70) 
Squatting or kneeling    
          Not at all 559 (65) 347 (63) 1 
          A little 260 (30) 144 (26) 1.09 (0.79, 1.51) 
          A lot 40 (5) 63 (11) 3.30 (1.95, 5.59) 
Lifting or moving heavy objects    
          Not at all 637 (75) 401 (72) 1 
          A little 200 (23) 124 (22) 1.00 (0.74, 1.34) 
          A lot 18 (2) 31 (6) 3.28 (1.62, 6.65) 
Going up and down ladders    
          Not at all 798 (94) 501 (90) 1 
          A little 34 (4) 34 (6) 2.10 (1.20, 3.66) 
          A lot 18 (2) 21 (4) 2.92 (1.35, 6.33) 
Slips, trips, sprains, and strains    
Slip, trip or fall    
          No 843 (98) 536 (96) 1 
          Yes 16 (2) 23 (4) 2.33 (1.11, 4.86) 
Episode of buckling or giving way    
          No 788 (93) 377 (68) 1 
          Yes 64 (8) 178 (32) 9.06 (5.86, 13.99) 
Health and healthcare use    
Reduce or miss medication    
          No 792 (93) 535 (96) 1 
          Yes 60 (7) 20 (4) 0.34 (0.18, 0.63) 
Take extra pain medication in 
anticipation of increased activity/busier 
   
          No 800 (94) 439 (79) 1 
          Yes 52 (6) 120 (21) 5.37 (3.48, 8.28) 
Cough, cold or other minor infection    
          No 668 (78) 448 (80) 1 












    
           Table III. Continued… 








OR (95% CI) 
Stress and other things    
Work-related stress    
          No 790 (93) 506 (91) 1 
          Yes 59 (7) 49 (9) 1.16 (0.72, 1.88) 
Home-related stress    
          No 767 (89) 484 (86) 1 
          Yes 92 (11) 77 (14) 1.32 (0.90, 1.93) 
Friend/family-related stress    
          No 779 (91) 498 (89) 1 
          Yes 80 (9) 63 (11) 1.11 (0.73, 1.68) 
Low mood/depressed    
          No 728 (85) 404 (72) 1 
          Yes 132 (15) 158 (28) 2.30 (1.67, 3.16) 
Feeling angry, irritable or hostile    
          No 760 (89) 453 (80) 1 
          Yes 98 (11) 112 (20) 2.04 (1.43, 2.90) 
Poor night’s sleep    
          No 515 (60) 216 (39) 1 
          Yes 345 (40) 342 (61) 3.04 (2.29, 4.02) 
Generally cold and damp weather    
          No 373 (43) 203 (36) 1 
          Yes 486 (57) 358 (64) 1.45 (1.12, 1.87) 
              OR, odds ratio; CI, confidence interval.  
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